p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression

被引:117
作者
Sun, YB
Sun, Y
Wenger, L
Rutter, JL
Brinckerhoff, CE
Cheung, HS
机构
[1] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33101 USA
[2] Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA
[3] Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Mol Biol, Ann Arbor, MI 48105 USA
[4] Dartmouth Coll, Sch Med, Dept Pharmacol Toxicol, Hanover, NH 03755 USA
[5] Dartmouth Coll, Sch Med, Dept Med, Hanover, NH 03755 USA
关键词
D O I
10.1074/jbc.274.17.11535
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies show that the p53 tumor suppressor protein is overexpressed in rheumatoid arthritis (RA) synovium and that somatic mutations previously identified in human tumors are present in RA synovium (Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J., and Green, D. R. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10895-10900; Firestein, G. S., Nguyen, K., Aupperle, K. R, Yeo, M., Boyle, D. L., and Zvaifler, N. J. (1996) Am. J. Pathol. 149, 2143-2151; Reme, T., Travaglio, A., Gueydon, E., Adla, L, Jorgensen, C., and Sany, J. (1998) Clin. Exp. Immunol. 111, 353-3581). We hypothesize that the abnormality of p53 seen in RA synovium may contribute to joint degeneration through the regulation of human matrix metalloproteinase-1 (hMMP-1, collagenase-1) gene expression. Transcription assays were performed with luciferase reporters driven by the promoter of the hMMP-1 gene or by a minimal promoter containing tandem repeats of the consensus binding sequence for activator protein-1, cotransfected with p53-expressing plasmids, The results revealed that (i) wild-type (wt) p53 down-regulated the promoter activity of hMMP-1 in a dose-dependent fashion; (ii) four of six p53 mutants (commonly found in human cancers) lost this repression activity; and (iii) this p53 repression activity was mediated at least in part by the activator protein-1 sites found in the hMMP-1 promoter. These findings were further confirmed by Northern analysis. The down-regulation of hMMP-1 gene expression by endogenous wt-p53 was shown by treatment of U2-OS cells, a wt-p53-containing osteogenic sarcoma line, and Saos-2 cells, a p53-negative osteogenic sarcoma line, with etoposide, a potent inducer of p53 expression. p53, activated by etoposide, appears to block hMMP-1 promoter activity induced by etoposide in U2-OS cells. In summary, we have shown for the first time that the hMMP-1 gene is a p53 target gene, subject to p53 repression. Because MMP-1 is principally responsible for the irreversible destruction of collagen in articular tissue in RA, abnormality of p53 may contribute to joint degeneration through the regulation of MMP-1 expression.
引用
收藏
页码:11535 / 11540
页数:6
相关论文
共 54 条
[1]   REGULATION OF THE HUMAN HSP70 PROMOTER BY P53 [J].
AGOFF, SN ;
HOU, J ;
LINZER, DIH ;
WU, B .
SCIENCE, 1993, 259 (5091) :84-87
[2]   Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor [J].
Aho, S ;
Rouda, S ;
Kennedy, SH ;
Qin, HP ;
Tan, EML .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 247 (02) :503-510
[3]  
AREND WP, 1993, TXB RHEUMATOLOGY, P227
[4]   THE AP-1 SEQUENCE IS NECESSARY BUT NOT SUFFICIENT FOR PHORBOL INDUCTION OF COLLAGENASE IN FIBROBLASTS [J].
AUBLE, DT ;
BRINCKERHOFF, CE .
BIOCHEMISTRY, 1991, 30 (18) :4629-4635
[5]  
Aupperle KR, 1998, AM J PATHOL, V152, P1091
[6]   Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter [J].
Bian, JH ;
Sun, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6330-6338
[7]   Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases [J].
Borden, P ;
Heller, RA .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1997, 7 (1-2) :159-178
[8]  
BORELLINI F, 1993, J BIOL CHEM, V268, P7923
[9]  
BRINCKERHOFF C E, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P145
[10]  
Caron De Fromentel Claude, 1992, Genes Chromosomes and Cancer, V4, P1